Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

JA, French; AM, Kanner; J, Bautista; B, Abou-Khalil; T, Browne; CL, Harden; WH, Theodore; C, Bazil; J, Stern; SC, Schachter; D, Bergen; D, Hirtz; GD, Montouris; M, Nespeca; B, Gidal; WJ Jr, Marks; WR, Turk; JH, Fischer; B, Bourgeois; A, Wilner; RE Jr, Faught; RC, Sachdeo; A, Beydoun; TA, Glauser

doi:10.1212/01.wnl.0000123695.22623.32

Public

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Shared by NobleBlocks on Apr 1, 2004 • 12:00 AM UTC

Authors:

French JA

Kanner AM

Bautista J

Abstract

<h4>Objective</h4>To assess the evidence demonstrating efficacy, tolerability, and safety of seven new antiepileptic drugs (AEDs) (gabapentin, lamotrigine, topiramate, tiagabine, oxcarbazepine, levetiracetam, and zonisamide) in the treatment of children and adults with refractory partial and general...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!